FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE — Original Application (KVK-Tech, Inc.)

View source ↗

Summary

The FDA approved KVK-Tech's methylphenidate hydrochloride extended-release as a generic drug through an Original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

ORIG AP for METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE (METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE)